Dr. Aaron Kowalski: Civica Announcement

 

We are thrilled to announce that JDRF is supporting Civica’s newly established program to develop affordable insulin. Civica is a nonprofit generic drug manufacturing company founded by leading health systems. Civica will manufacture and distribute biosimilar insulin options with a recommended consumer price of no more than $30/vial and $55/box of 5 pen cartridges, regardless of insurance status. This project will significantly lower the cost of insulin for millions of Americans and, most importantly, save lives.